The overall goal of this project is to examine in humans the role of nitric oxide (NO) in three aspects of normal myocardial and vascular regulation, and to test the general hypothesis that abnormalities of NO regulation contribute to the pathophysiology of patients with congestive heart failure (CHF). NO's role as a paracrine autacoid regulator of vascular tone is well appreciated, and increasing evidence now implicates abnormalities of NO-dependent regulation of the systemic and coronary vasculature in CHF. In normal myocardium, NO elaborated by microvascular endothelial cells an myocytes may affect cardiac myocyte function by modulating beta-adrenergic and muscarinic cholinergic responses. In certain pathologic states, cytokine-induced overexpression of myocardial NO may depress systolic and diastolic function. There is now reason to believe that abnormal NO regulation may contribute to several incompletely understood aspects of the pathophysiology of CHF. We will use local intracoronary and intrapulmonary artery infusions of NG-monomethyl-1-arginine (:L-NMMA), an inhibitor of NOS alone and in conjunction with a variety of chemical and physiologic stimuli, to address the role of NO in humans with CHF due to idiopathic and ischemic dilated cardiomyopathy, myocarditis and human immunodeficiency virus-related myocarditis/cardiomyopathy. For comparison, we will study humans with normal myocardial hemodynamic function. We will focus on three areas that have not previously been addressed in humans.
In Specific Aim 1, we will test the hypotheses that 1) No plays a role in modulating basal and autonomically-mediated changes in systolic and diastolic myocardial function in normal humans, and 2) abnormal regulation of cardiac NO contributes to left ventricular dysfunction in patients with CHF due to several etiologies.
In Specific Aim 2, we will test the hypotheses that 1) NO plays a role in metabolic coronary resistance vessel regulation in normal humans, and 2) abnormal NO regulation contributes to reduced metabolic stimulation of coronary blood flow in patients with idiopathic dilated cardiomyopathy.
In Specific Aim 3, we will utilize a novel approach for the direct assessment of pulmonary vascular tone to test the hypotheses that 1) NO plays a role in regulating pulmonary vascular tone in normal humans, and 2) abnormal NO-dependent vasodilator function contributes to pulmonary hypertension in patients with CHF at rest and with increased pulmonary blood flow.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL052320-05
Application #
6110368
Study Section
Project Start
1999-01-01
Project End
1999-12-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
5
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Herman, Daniel S; Lam, Lien; Taylor, Matthew R G et al. (2012) Truncations of titin causing dilated cardiomyopathy. N Engl J Med 366:619-28
Alcalai, Ronny; Wakimoto, Hiroko; Arad, Michael et al. (2011) Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation. J Cardiovasc Electrophysiol 22:316-24
Pinz, Ilka; Zhu, Ming; Mende, Ulrike et al. (2011) An improved isolation procedure for adult mouse cardiomyocytes. Cell Biochem Biophys 61:93-101
Shen, Weiqun; Vatner, Dorothy E; Vatner, Stephen F et al. (2010) Progressive loss of creatine maintains a near normal DeltaG approximately (ATP) in transgenic mouse hearts with cardiomyopathy caused by overexpressing Gsalpha. J Mol Cell Cardiol 48:591-9
Saltzman, Adam J; Mancini-DiNardo, Debora; Li, Chumei et al. (2010) Short communication: the cardiac myosin binding protein C Arg502Trp mutation: a common cause of hypertrophic cardiomyopathy. Circ Res 106:1549-52
Gnecchi, Massimiliano; He, Huamei; Melo, Luis G et al. (2009) Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells 27:971-9
Pinz, Ilka; Ostroy, Sanford E; Hoyer, Kirsten et al. (2008) Calcineurin-induced energy wasting in a transgenic mouse model of heart failure. Am J Physiol Heart Circ Physiol 294:H1459-66
Pinz, Ilka; Robbins, Jeffrey; Rajasekaran, Namakkal S et al. (2008) Unmasking different mechanical and energetic roles for the small heat shock proteins CryAB and HSPB2 using genetically modified mouse hearts. FASEB J 22:84-92
Pinz, Ilka; Wax, Stephen D; Anderson, Paul et al. (2008) Low over-expression of TNFalpha in the mouse heart increases contractile performance via TNFR1. J Cell Biochem 105:99-107
Hoyer, Kirsten; Krenz, Maike; Robbins, Jeffrey et al. (2007) Shifts in the myosin heavy chain isozymes in the mouse heart result in increased energy efficiency. J Mol Cell Cardiol 42:214-21

Showing the most recent 10 out of 98 publications